HF
DWTX

HRT Financial’s Dogwood Therapeutics DWTX Stock Holding History

HRT Financial’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,228
Closed -$56K – 3730
2025
Q1 		$56K Buy
+11,228
New +$76K ﹤0.01% 2230
2024
Q4 		– Sell
-3,263
Closed -$13K – 3434
2024
Q3 		$13K Buy
3,263
+961
+42% +$4.98K ﹤0.01% 2220
2024
Q2 		$12K Buy
+2,302
New +$19.9K ﹤0.01% 1989

Other funds holding DWTX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

HRT Financial's DWTX Position: Q2 2025 in Review

HRT Financial sold out of Dogwood Therapeutics (DWTX) in Q2 2025, closing a stake of 11,228 shares — an estimated $56K sold.

HRT Financial first reported a position in DWTX in Q2 2024 and held it in 3 quarters. The position peaked at $56K in Q1 2025. 10 funds tracked by Wall St. Rank hold DWTX as of Q2 2025.

  • HRT Financial reported no remaining Dogwood Therapeutics position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 11,228 Dogwood Therapeutics shares in Q2 2025, an estimated $56K.
  • HRT Financial first reported a position in Dogwood Therapeutics in Q2 2024 and held it in 3 quarters.
  • HRT Financial's Dogwood Therapeutics position peaked at $56K in Q1 2025.
  • 10 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.